Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ISB 2001 |
Trade Name | |
Synonyms | ISB2001|ISB-2001 |
Drug Descriptions |
ISB 2001 is a trispecific T-cell engager targeting CD3 on T cells and BCMA and CD38 on tumor cells, which potentially decreases tumor growth (Blood (2022) 140 (Supplement 1): 858-859). |
DrugClasses | CD3 Antibody 99 CD38 Antibody 20 TNFRSF17 Antibody 20 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ISB 2001 | ISB 2001 | 0 | 1 |